CliffBio

Noven Pharmaceuticals

Patent cliffs & loss of exclusivity

Small Molecules

Company

CAGE Code7GXL5
Company Operating StatusActive
Full Address100 Town Square, 5th Floor Jersey City, NJ 07310
LinkedIn URLhttps://www.linkedin.com/company/noven-pharmaceuticals/
Pitchbook URLhttps://pitchbook.com/profiles/company/10959-67#overview
Official Websitehttp://noven.com

9 upcoming patent cliffs

DrugIngredientTypeCliff
  1. MINIVELLEESTRADIOLSmall mol.Jul 2030
  2. MINIVELLEESTRADIOLSmall mol.Jul 2030
  3. MINIVELLEESTRADIOLSmall mol.Jul 2030
  4. MINIVELLEESTRADIOLSmall mol.Jul 2030
  5. MINIVELLEESTRADIOLSmall mol.Jul 2030
  6. XELSTRYMDEXTROAMPHETAMINESmall mol.Jan 2042
  7. XELSTRYMDEXTROAMPHETAMINESmall mol.Jan 2042
  8. XELSTRYMDEXTROAMPHETAMINESmall mol.Jan 2042
  9. XELSTRYMDEXTROAMPHETAMINESmall mol.Jan 2042
  10. ESKALITHLITHIUM CARBONATESmall mol.—
  11. DENTIPATCHLIDOCAINESmall mol.—
  12. COMBIPATCHESTRADIOL; NORETHINDRONE ACETATESmall mol.—
  13. COMBIPATCHESTRADIOL; NORETHINDRONE ACETATESmall mol.—
  14. DAYTRANAMETHYLPHENIDATESmall mol.—
  15. DAYTRANAMETHYLPHENIDATESmall mol.—
  16. DAYTRANAMETHYLPHENIDATESmall mol.—
  17. DAYTRANAMETHYLPHENIDATESmall mol.—
  18. FENTANYL-100FENTANYLSmall mol.—
  19. FENTANYL-25FENTANYLSmall mol.—
  20. FENTANYL-50FENTANYLSmall mol.—
  21. FENTANYL-75FENTANYLSmall mol.—
  22. DENTIPATCHLIDOCAINESmall mol.—
  23. LIDOCAINELIDOCAINESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.